Franklin Resources Inc Eye Point Pharmaceuticals, Inc. Put Options Transaction History
Franklin Resources Inc
- $343 Billion
- Q4 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|---|---|---|---|---|
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding EYPT
# of Institutions
156Shares Held
72.4MCall Options Held
187KPut Options Held
225K-
Cormorant Asset Management, LP Boston, MA8.33MShares$49.2 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$40.1 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$34 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$22.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$22.3 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $201M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...